RET - multiple endocrine neoplasia type 2
This test is available for the following conditions:
- Conditions > Hearing impairment > Multiple endocrine neoplasia type 2 (MEN2)
- Conditions > Endocrine > Multiple endocrine neoplasia type 2 (MEN2)
- Conditions > Oncogenetics > Multiple endocrine neoplasia type 2 (MEN2)
This product is also part of the following panels:
- WES hereditary cancer (100.0% *)
- WES hereditary cancer (100.0% *)
- WES Mendelian inherited disorders (100.0% *)
* % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)
Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Method
- Sequence analysis of selected exons and flanking intron-exon boundaries
Analysis of exons 10, 11, 13-16 only. With this test all known mutations are detected and explain 98% of the MEN2 patients.
OMIM:
164761
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane